CD44 and pancreatic neoplasm: We further analyzed this correlation in the TCGA pancreatic cancer database using Ualcan (http://ualcan.path.uab.edu/, accessed on 8 May 2021) and arrived at a similar result: high CD44 expression predicted poor prognosis (Figure 1C).